• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Anti-EGF antibody cationic polymeric liposomes for delivery of the p53 gene for ovarian carcinoma therapy.用于递送p53基因以治疗卵巢癌的抗表皮生长因子(EGF)抗体阳离子聚合物脂质体
Int J Clin Exp Pathol. 2019 Jan 1;12(1):205-211. eCollection 2019.
2
Stealth cationic liposomes modified with anti-CAGE single-chain fragment variable deliver recombinant methioninase for gastric carcinoma therapy.用抗CAGE单链可变片段修饰的隐形阳离子脂质体递送重组蛋氨酸酶用于胃癌治疗。
J Nanosci Nanotechnol. 2013 Jan;13(1):178-83. doi: 10.1166/jnn.2013.6881.
3
Enhanced p53 gene transfer to human ovarian cancer cells using the cationic nonviral vector, DDC.使用阳离子非病毒载体DDC将增强型p53基因导入人卵巢癌细胞。
Gynecol Oncol. 2003 Aug;90(2):265-72. doi: 10.1016/s0090-8258(03)00248-8.
4
Systemic p53 gene therapy of cancer with immunolipoplexes targeted by anti-transferrin receptor scFv.使用抗转铁蛋白受体单链抗体片段靶向的免疫脂质体复合物对癌症进行全身性p53基因治疗。
Mol Med. 2001 Oct;7(10):723-34.
5
PEGylated DC-Chol/DOPE cationic liposomes containing KSP siRNA as a systemic siRNA delivery Carrier for ovarian cancer therapy.聚乙二醇化 DC-Chol/DOPE 阳离子脂质体包载 KSP siRNA 作为一种系统的 siRNA 传递载体用于卵巢癌治疗。
Biochem Biophys Res Commun. 2018 Sep 10;503(3):1716-1722. doi: 10.1016/j.bbrc.2018.07.104. Epub 2018 Jul 24.
6
Properties and evaluation of quaternized chitosan/lipid cation polymeric liposomes for cancer-targeted gene delivery.季铵化壳聚糖/脂质阳离子聚合物脂质体的性质及用于癌症靶向基因传递的评价。
Langmuir. 2013 Jul 9;29(27):8683-93. doi: 10.1021/la401166v. Epub 2013 Jun 27.
7
Co-delivery of plasmid DNA and antisense oligodeoxyribonucleotide into human carcinoma cells by cationic liposomes.通过阳离子脂质体将质粒DNA和反义寡脱氧核糖核苷酸共同递送至人癌细胞。
Curr Pharm Biotechnol. 2014;15(9):790-9. doi: 10.2174/1389201015666141020154352.
8
Gene transfection by cationic liposomes: comparison of the transfection efficiency of liposomes prepared from various positively charged lipids.阳离子脂质体介导的基因转染:不同带正电荷脂质制备的脂质体转染效率比较
Acta Med Okayama. 1997 Jun;51(3):149-54. doi: 10.18926/AMO/30793.
9
Small interfering RNA delivery into the liver by cationic cholesterol derivative-based liposomes.阳离子胆固醇衍生物脂质体介导的小干扰 RNA 递送至肝脏。
J Liposome Res. 2017 Dec;27(4):264-273. doi: 10.1080/08982104.2016.1205599. Epub 2016 Jul 21.
10
Cisplatin-alginate conjugate liposomes for targeted delivery to EGFR-positive ovarian cancer cells.顺铂-海藻酸钠缀合物脂质体用于靶向递送 EGFR 阳性卵巢癌细胞。
Biomaterials. 2014 May;35(14):4297-309. doi: 10.1016/j.biomaterials.2014.01.035. Epub 2014 Feb 22.

引用本文的文献

1
Advancements in -Based Anti-Tumor Gene Therapy Research.基于 的抗肿瘤基因治疗研究进展。
Molecules. 2024 Nov 11;29(22):5315. doi: 10.3390/molecules29225315.
2
Liposomal delivery of gene therapy for ovarian cancer: a systematic review.脂质体基因治疗卵巢癌的系统评价。
Reprod Biol Endocrinol. 2023 Aug 23;21(1):75. doi: 10.1186/s12958-023-01125-2.
3
Current Update on Nanotechnology-Based Approaches in Ovarian Cancer Therapy.基于纳米技术的卵巢癌治疗方法的最新进展。
Reprod Sci. 2023 Feb;30(2):335-349. doi: 10.1007/s43032-022-00968-1. Epub 2022 May 18.
4
Delivery of cancer therapies by synthetic and bio-inspired nanovectors.合成和仿生纳米载体递呈癌症治疗药物。
Mol Cancer. 2021 Mar 24;20(1):55. doi: 10.1186/s12943-021-01346-2.
5
Gene Therapy in Cancer Treatment: Why Go Nano?癌症治疗中的基因疗法:为何走向纳米?
Pharmaceutics. 2020 Mar 5;12(3):233. doi: 10.3390/pharmaceutics12030233.

本文引用的文献

1
Serum Heparin-binding Epidermal Growth Factor-like Growth Factor (HB-EGF) as a Biomarker for Primary Ovarian Cancer.血清肝素结合表皮生长因子样生长因子(HB-EGF)作为原发性卵巢癌的生物标志物。
Anticancer Res. 2017 Jul;37(7):3955-3960. doi: 10.21873/anticanres.11779.
2
Manufacturing of recombinant adeno-associated viral vectors for clinical trials.临床试验用重组腺相关病毒载体的制造。
Mol Ther Methods Clin Dev. 2016 Mar 16;3:16002. doi: 10.1038/mtm.2016.2. eCollection 2016.
3
Development of self-assembling peptide nanovesicle with bilayers for enhanced EGFR-targeted drug and gene delivery.具有双层结构的自组装肽纳米囊泡的构建及其用于增强表皮生长因子受体靶向药物和基因递送。
Biomaterials. 2016 Mar;82:194-207. doi: 10.1016/j.biomaterials.2015.12.015. Epub 2015 Dec 29.
4
Dosing and Safety Implications for Oncologists When Administering Everolimus to Patients With Hormone Receptor-Positive Breast Cancer.肿瘤学家在给激素受体阳性乳腺癌患者使用依维莫司时的给药剂量及安全性考量
Clin Breast Cancer. 2016 Feb;16(1):18-22. doi: 10.1016/j.clbc.2015.09.004. Epub 2015 Sep 29.
5
Peptide modules for overcoming barriers of nucleic acids transport to cells.用于克服核酸转运至细胞障碍的肽模块。
Curr Top Med Chem. 2016;16(3):330-42. doi: 10.2174/1568026615666150812120755.
6
Goat activin receptor type IIB knockdown by artificial microRNAs in vitro.利用人工微小RNA在体外敲低山羊IIB型激活素受体
Appl Biochem Biotechnol. 2014 Sep;174(1):424-36. doi: 10.1007/s12010-014-1071-3. Epub 2014 Jul 31.
7
Lipid-like self-assembling peptide nanovesicles for drug delivery.用于药物递送的类脂质自组装肽纳米囊泡
ACS Appl Mater Interfaces. 2014 Jun 11;6(11):8184-9. doi: 10.1021/am501673x. Epub 2014 May 21.
8
Properties and evaluation of quaternized chitosan/lipid cation polymeric liposomes for cancer-targeted gene delivery.季铵化壳聚糖/脂质阳离子聚合物脂质体的性质及用于癌症靶向基因传递的评价。
Langmuir. 2013 Jul 9;29(27):8683-93. doi: 10.1021/la401166v. Epub 2013 Jun 27.
9
Liver-specific expression of an exogenous gene controlled by human apolipoprotein A-I promoter.受人类载脂蛋白 A-I 启动子控制的外源基因在肝脏中的特异性表达。
Int J Pharm. 2010 Oct 15;398(1-2):161-4. doi: 10.1016/j.ijpharm.2010.07.023. Epub 2010 Jul 23.
10
Development of bacterial vectors for tumor-targeted gene therapy.用于肿瘤靶向基因治疗的细菌载体的研发。
Methods Mol Biol. 2009;542:131-54. doi: 10.1007/978-1-59745-561-9_7.

用于递送p53基因以治疗卵巢癌的抗表皮生长因子(EGF)抗体阳离子聚合物脂质体

Anti-EGF antibody cationic polymeric liposomes for delivery of the p53 gene for ovarian carcinoma therapy.

作者信息

Zuo Li, Zhang Fengchun, Xu Yingchun

机构信息

Department of Oncology, Fudan University Shanghai Cancer Center, Minhang Branch Shanghai, China.

Department of Oncology, Suzhou Kowloon Hospital, Shanghai Jiao Tong University Suzhou, China.

出版信息

Int J Clin Exp Pathol. 2019 Jan 1;12(1):205-211. eCollection 2019.

PMID:31933735
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6944014/
Abstract

Cationic polymeric liposomes (CPLs) were successfully prepared using a tumor-targeting EGF protein modification for the systemic delivery of the p53 gene in ovarian cancer. These functional CPL nanoparticles (NPs) can be used as effective gene delivery vectors and are composed of an EGF derivative (EGF-GHDC), cholesterol, and DOPE, which have lower gene transfection efficiencies compared with Lipofectamine 2000. The increased therapeutic efficiency of p53 gene-loaded EGF-CPL was tested in SKOV3 cells and compared with p53 gene-loaded CPL and free p53 gene in solution. In addition, EGF-CPL (effective diameter: 95.01±4.05 nm; polydispersity index: 0.270) significantly enhanced luciferase gene expression in vivo 3 days post-injection of pGL-3/NPs complexes. In conclusion, EGF-targeted CPL has the potential for use as an effective drug delivery system.

摘要

通过对表皮生长因子(EGF)蛋白进行肿瘤靶向修饰,成功制备了阳离子聚合物脂质体(CPL),用于卵巢癌中p53基因的全身递送。这些功能性CPL纳米颗粒(NP)可作为有效的基因递送载体,由一种EGF衍生物(EGF-GHDC)、胆固醇和二油酰磷脂酰乙醇胺(DOPE)组成,与Lipofectamine 2000相比,其基因转染效率较低。在SKOV3细胞中测试了负载p53基因的EGF-CPL的治疗效果增强情况,并与负载p53基因的CPL和溶液中的游离p53基因进行了比较。此外,在注射pGL-3/NP复合物3天后,EGF-CPL(有效直径:95.01±4.05 nm;多分散指数:0.270)在体内显著增强了荧光素酶基因表达。总之,EGF靶向CPL有潜力用作有效的药物递送系统。